The landscape of radiotherapy is undergoing a significant transformation, driven by the integration of artificial intelligence and the rise of adaptive treatment protocols. As these technologies become standard, the traditional methods of Quality Assurance (QA) are being re-evaluated to keep pace with more complex and dynamic clinical workflows.
The Shift to Adaptive Treatments
Modern radiotherapy no longer relies solely on static plans. Adaptive treatments allow clinicians to adjust radiation doses in real-time based on changes in a patient's anatomy or tumor position. This shift requires QA systems that can validate changes instantly, ensuring that the precision of the delivery matches the sophistication of the planning software.
AI and Automation in the QA Workflow
Automation is becoming a critical component in managing the increasing volume of data generated during cancer treatment. By leveraging AI, medical physicists can streamline repetitive tasks and identify potential errors with greater speed and accuracy than manual reviews. However, this transition also presents new challenges in verifying the algorithms themselves and maintaining a human-in-the-loop oversight to guarantee safety standards.
As the industry moves forward, redefining QA is not just about adopting new tools, but about creating a holistic framework that supports the speed of modern oncology while maintaining the highest levels of clinical integrity.
